News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Ikaria Inc. Files for $200 Million IPO
May 14, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
PE Hub -- Ikaria, a Clinton, N.J.-based biopharma company, has filed for a $200 million IPO. It plans to trade on the Nasdaq under ticker symbol IKAR, with Goldman Sachs and Morgan Stanley serving as co-lead underwriters.
Twitter
LinkedIn
Facebook
Email
Print
IPO
MORE ON THIS TOPIC
Radiopharmaceuticals
Regeneron enters radiopharma ring with up to $4.3B Telix alliance
April 13, 2026
·
2 min read
·
Tristan Manalac
IPO tracker
Seaport, Hemab set sail for Nasdaq
April 13, 2026
·
9 min read
·
Tristan Manalac
Deals
Roche sticks with C4T, adding up to $1B for molecular glue partnership
April 9, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Merck Chopped $1B Off Terns’ Offer After Seeing Updated Leukemia Data
April 8, 2026
·
3 min read
·
Tristan Manalac
